Predictive value of CRP/albumin ratio for in-hospital atrial fibrillation development in ST segment elevation myocardial infarction

Aim: Atrial fibrillation(AF) development in ST elevation myocardial infarction (STEMI) patients is associated with increasedcardiovascular mortality and morbidity. The CRP to Albumin ratio(CAR) is a new described parameter and it has been suggestedthat this parameter may also be correlated with cardiovascular diseases. In this study, we investigated the association between AFdevelopment and the CAR in STEMI patients undergoing percutaneous coronary intervention.Material and Methods: This study was conducted in patients presenting to our department with a diagnosis of STEMI retrospectivelyand undergoing percutaneous coronary intervention. A total of 110 patients were included in the study. The patients were dividedinto two groups according to AF development and the predictors for AF development were investigated.Results: The mean age of the patients was 62±5.1 years and 72% of them were males. While CAR, TIMI, CRP, albumin, neutrophilto lymphocyte to ratio, lesion localization, myocardial blush grade and syntax score were associated with the AF development inthe univariate analysis, the CAR was determined to be an independent predictor of AF development in the multivariate regressionanalysis.Conclusions: We have demonstrated that the CAR was an independent predictor for prediction of AF development and we think thatthis parameter may be useful in clinical practice.

PDF

___

1. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention 2015;10:1024-94.
2. Levine GN, Bates ER, Blankenship JC, B et al. 2015 ACC/ AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of STelevation myocardial infarction: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the society for cardiovascular angiography and interventions. Circulation 2016;133:1135-47.
3. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). G Ital Cardiol (Rome). 201617:831-72.
4. Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017;389:197-210.
5. Morin DP, Bernard ML, Madias C, et al The State of the Art: Atrial Fibrillation Epidemiology, Prevention, and Treatment. Mayo Clin Proc 2016;91:1778-810.
6. Gorenek B, Kudaiberdieva G. Atrial fibrillation in acute STelevation myocardial infarction: clinical and prognostic features. Curr Cardiol Rev 2012;8:281-9.
7. Asselbergs FW, van den Berg MP, Diercks GF, et al. C-reactive protein and microalbuminuria are associated with atrial fibrillation. Int J Cardiol 2005;98:73-7.
8. Karabag Y, Cagdas M, Rencuzogullari I, et al. Relationship between C-reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris. J Clin Lab Anal 2018:e22457.
9. Geng HH, Wang XW, Fu RL, et al. The relationship between C-Reactive protein level and discharge outcome in patients with acute ischemic stroke. Int J Environ Res Public Health 2016;13:pii:E636
10. Nerlekar N, Ha FJ, Verma KP, et al. Percutaneous coronary intervention using drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary artery stenosis: A meta-analysis of randomized trials. Circ Cardiovasc Interv 2016;9:pii: e004729
11. Hendriks T, Hartman MHT, Vlaar PJJ, et al. Predictors of left ventricular remodeling after ST-elevation myocardial infarction. Int J Cardiovasc Imaging 2017;33:1415-23.
12. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1:219-27.
13. Chakrabarti AK, Gibson CM. The SYNTAX score: usefulness, limitations, and future directions. J Invasive Cardiol 2011;23:511-2.
14. Cid Alvarez AB, Gomez-Pena F, Redondo-Dieguez A, et al. Prognostic impact of SYNTAX II score in patients with ST-elevation myocardial infarction undergoing Primary Percutaneous Coronary Intervention: analysis of a 4-year all-comers registry. EuroIntervention 2018: pii: EIJ-D-18-00561.
15. Cerqueira Junior A, Pereira L, Souza TMB, et al. Prognostic Accuracy of the GRACE Score in Octogenarians and Nonagenarians with Acute Coronary Syndromes. Arq Bras Cardiol 2018;110:24-9.
16. Oh TK, Ji E, Na HS, et al. C-Reactive protein to albumin ratio predicts 30-day and 1-year mortality in postoperative patients after admission to the intensive care unit. J Clin Med 2018;7.
17. Khera AV, Demler OV, Adelman SJ, et al. cholesterol efflux capacity, high-Density Lipoprotein particle number, and incident cardiovascular events: an analysis from the JUPITER trial (Justification for the use of statins in prevention: aan intervention trial evaluating rosuvastatin). circulation 2017;135:2494-504.
18. Karabag Y, Cagdas M, Rencuzogullari I, et al. The C-Reactive Protein to Albumin ratio predicts acute kidney Injury in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Heart Lung Circ 2018;pii:S1443-9506:31863-8.
19. Park JE, Chung KS, Song JH, et al. The C-Reactive Protein/ Albumin Ratio as a Predictor of Mortality in Critically Ill Patients. J Clin Med 2018;7:pii: E333.
20. Ni XF, Wu J, Ji M, et al. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer. Asia Pac J Clin Oncol 2018;14:402-9.
21. Liu Y, Chen S, Zheng C, et al. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer. BMC Cancer 2017;17:285.
22. Cinar T, Cagdas M, Rencuzogullari I, et al. Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction. Scand Cardiovasc J 2019:53:83-90.
23. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/ HRS guideline for the management of patients with atrial fibrillation: a report of the American college of cardiology/ American heart association task force on practice guidelines and the heart rhythm society. J Am Coll Cardiol 2014;64:1- 76.